Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagué J.
Cell. 2017 Mar 9;168(6):1101-1113.e13. doi: 10.1016/j.cell.2017.02.025.
PMID:28283064
Disrupting the CD47-SIRPalpha anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.
Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, Storm TA, Schubert S, Hutter G, Narayanan C, Chu P, Raabe EH, Harsh G 4th, Taylor MD, Monje M, Cho YJ, Majeti R, Volkmer JP, Fisher PG, Grant G, Steinberg GK, Vogel H, Edwards M, Weissman IL, Cheshier SH.
Sci Transl Med. 2017 Mar 15;9(381):eaaf2968. doi: 10.1126/scitranslmed.aaf2968.
PMID:28298418
Meningeal carcinomatosis.
HAWKINS D, BROWN D.
Can Med Assoc J. 1963 Feb 2;88(5):225-8.
PMID:13953212
Pediatric Malignant Peritoneal Mesothelioma With Meningeal Metastasis.
Aldrian D, Neu N, Oberhuber G, Kropshofer G, Müller T, Vogel GF.
J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e272-e274. doi: 10.1097/MPH.0000000000002118.